ACCURACY + EARLY DETECTION
IR Medtek’s technology has the ability to improve the accuracy and early detection of many types of cancer. We make use of light detection technology and advanced algorithms combined with machine learning to yield powerful results.
ABOUT IR MEDTEK
IR Medtek LLC was founded in 2019 in collaboration with the Ohio State Innovation Fund by Doug Cohen, Andy Spector, and two other co-founders. The company exclusively licensed the groundbreaking technology developed at The Ohio State University and the James Cancer Hospital for early non-invasive detection of skin and other cancers.